PT1159968E - Estirpes atenuadas de vírus do dengue e a sua utilização numa composição de vacina - Google Patents

Estirpes atenuadas de vírus do dengue e a sua utilização numa composição de vacina Download PDF

Info

Publication number
PT1159968E
PT1159968E PT00420113T PT00420113T PT1159968E PT 1159968 E PT1159968 E PT 1159968E PT 00420113 T PT00420113 T PT 00420113T PT 00420113 T PT00420113 T PT 00420113T PT 1159968 E PT1159968 E PT 1159968E
Authority
PT
Portugal
Prior art keywords
dengue virus
attenuated strains
vaccine composition
serotype
attenuated
Prior art date
Application number
PT00420113T
Other languages
English (en)
Inventor
Nath Bhamarapravat
Sutee Yoksan
Original Assignee
Univ Mahidol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mahidol filed Critical Univ Mahidol
Publication of PT1159968E publication Critical patent/PT1159968E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT00420113T 2000-05-30 2000-05-30 Estirpes atenuadas de vírus do dengue e a sua utilização numa composição de vacina PT1159968E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00420113A EP1159968B1 (fr) 2000-05-30 2000-05-30 Souches atténuées du virus de la Dengue et leur utilisation dans une composition vaccinale

Publications (1)

Publication Number Publication Date
PT1159968E true PT1159968E (pt) 2008-11-20

Family

ID=8174060

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00420113T PT1159968E (pt) 2000-05-30 2000-05-30 Estirpes atenuadas de vírus do dengue e a sua utilização numa composição de vacina

Country Status (7)

Country Link
EP (1) EP1159968B1 (pt)
AT (1) ATE412738T1 (pt)
CY (1) CY1108666T1 (pt)
DE (1) DE60040652D1 (pt)
DK (1) DK1159968T3 (pt)
ES (1) ES2315221T3 (pt)
PT (1) PT1159968E (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006134443A1 (en) 2005-06-17 2006-12-21 Sanofi Pasteur Dengue serotype 2 attenuated strain
MX2007015873A (es) * 2005-06-17 2008-04-22 Sanofi Pasteur Cepa atenuada de virus de dengue serotipo 1.
US7968102B2 (en) 2006-01-13 2011-06-28 Sanofi Pasteur S.A. Dengue chimeric viruses
AR061197A1 (es) * 2006-06-07 2008-08-13 Sanofi Pasteur Cepas del virus 3 del dengue vivas atenuadas
FR2903605A1 (fr) 2006-07-12 2008-01-18 Sanofi Pasteur Sa Methode d'immunisation contre les quatres serotypes de la dengue
FR2906724B1 (fr) 2006-10-04 2009-03-20 Sanofi Pasteur Sa Methode d'immunisation contre les 4 serotypes de la dengue.
FR2909286B1 (fr) 2006-12-01 2012-06-08 Sanofi Pasteur Methode d'immunisation contre les 4 serotypes de la dengue
EP2589392B1 (en) 2008-03-05 2016-11-30 Sanofi Pasteur Process for stabilizing an adjuvant containing vaccine composition
EP2143440A1 (fr) 2008-07-09 2010-01-13 Sanofi Pasteur Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués
EP2353609A1 (en) 2010-02-04 2011-08-10 Sanofi Pasteur Immunization compositions and methods
MY168959A (en) 2012-07-24 2019-01-28 Sanofi Pasteur Vaccine compositions for the prevention of dengue virus infection
AU2013295016A1 (en) 2012-07-24 2015-01-29 Sanofi Pasteur Vaccine compositions for prevention against dengue virus infection
BR112015012515B1 (pt) 2012-11-30 2023-04-11 Sanofi Pasteur Uso de antígenos, construções de ácido nucleico ou vetores virais capazes de expressar uma partícula do tipo vírus (vlp) da dengue e de uma vacina contra sarampo, uma vacina contra caxumba e uma vacina contra rubéola
CA3177572A1 (en) * 2013-03-15 2014-09-25 Takeda Vaccines, Inc. Compositions and methods for dengue virus chimeric constructs in vaccines
KR102297300B1 (ko) 2015-11-27 2021-09-02 케이엠 바이올로직스 가부시키가이샤 뎅기 바이러스 약독주를 뱅크화한 생바이러스, 및 그것들을 항원으로 하는 뎅기 백신
WO2017109698A1 (en) 2015-12-22 2017-06-29 Glaxosmithkline Biologicals Sa Immunogenic formulation
WO2019069130A1 (en) 2017-10-05 2019-04-11 Sanofi Pasteur COMPOSITIONS FOR RECALL VACCINATION AGAINST DENGUE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6093296A (en) * 1995-06-07 1996-12-30 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Infectious dengue 2 virus pdk-53 as quadravalent vaccine

Also Published As

Publication number Publication date
DE60040652D1 (de) 2008-12-11
EP1159968B1 (fr) 2008-10-29
CY1108666T1 (el) 2014-04-09
DK1159968T3 (da) 2009-02-23
EP1159968A1 (fr) 2001-12-05
ATE412738T1 (de) 2008-11-15
ES2315221T3 (es) 2009-04-01

Similar Documents

Publication Publication Date Title
PT1159968E (pt) Estirpes atenuadas de vírus do dengue e a sua utilização numa composição de vacina
AU5242000A (en) Nematicidal trifluorobutenes
AU7144901A (en) Human papilloma virus treatment
WO2001096353A3 (en) 3'-PRODRUGS OF 2'-DEOXY-β-L-NUCLEOSIDES
RS50362B (sr) Sastavi estrogen-ciklodekstrin kompleksa
AU6093296A (en) Infectious dengue 2 virus pdk-53 as quadravalent vaccine
AU6350699A (en) Chemical compounds
AU6160200A (en) New bifidobacteria preventing diarrhea caused by pathogenic bacteria
HK1043809B (zh) 對抗乳頭瘤病毒感染及腫瘤的藥物成份
NZ238340A (en) Preparation of 3-(methylamino)-piperidine derivatives
CA2062779A1 (en) Sterilizing gas composition comprising monochlorotetrafluorethane and ethylene oxide
IL137794A0 (en) Streptogramin derivatives, preparation method and compositions containing same
DK1204659T3 (da) Serotonerge benzofuraner
AU2002218322A1 (en) Substituted cyclohexenes
WO2002028362A3 (fr) Composition vaccinale et procede de stabilisation
NO820820L (no) Fremgangsmaate ved fremstilling av 2,9-dioxatricyclo (4,3,1,0 3,7)decaner
ITRM920408A1 (it) Colture di tessuto di mucosa congiuntivale differenziata, procedimento per la loro preparazione e supporti per il loro uso.
DE60236623D1 (de) Amorphe substanz eines tricyclischen triazolobenzazepinderivats
MXPA01003968A (es) Mutantes de pestivirus y vacunas que contienen los mismos.
MY134141A (en) "glyoxal-phenolic condensates with enhanced fluoroescence"
AU632696B2 (en) New strains of drechslera spp., and weed control agents and weed control compositions containing the same
EE05184B1 (et) Kaloporosiidi derivaadid, nende valmistamine ja kasutamine ravimina, neid sisaldavad ravimid ning mikroorganismi Gloeoporus dichrous (Fr.:Fr.) tvi ST001714 (DSM 13784)
WO2002088292A8 (en) Radical initiator composition
UA37622A (uk) 1,5-піперидил - 3,7-біс/діетаноламіну/ - піримідил ізовалеріанат, що використовується для діагностики вірусних інфекцій